A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: Antibody responses, safety, and immunologic memory
Wm. Cassidy et al., A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: Antibody responses, safety, and immunologic memory, PEDIATRICS, 107(4), 2001, pp. 626-631
Objectives. Hoping to increase hepatitis B (HB) vaccination of adolescents,
we did the following: 1) studied if modified regimens of the recombinant H
B vaccine, Recombivax HB (2 or 3 doses of 5 or 10 mug given over 4 or 6 mon
ths), induce protective anti-hepatitis B surface antibody [anti-HBsAb] leve
ls (greater than or equal to 10 mIU/mL) comparable to the recommended regim
en (5 mug at 0 and 1, and 6 months); 2) measured early antibody response af
ter a single dose; and 3) assessed immunologic memory after 2- and 3-dose r
egimens.
Design. One thousand twenty-six adolescents were randomized to 1 of 5 treat
ment groups (10 mug at 0 and 4 or 0 and 6 months; 5 mug at 0 and 6 or 0, 2,
and 4 or 0, 1, and 6 months) in an open trial. Anti-HBsAb was measured in
all participants just before and 1 month after the last dose, and at severa
l other times in a subset of vaccinees. Anti-HBsAb response to a booster do
se 2 years later was examined to assess immunologic memory in participants
vaccinated with 5 mug at 0 and 6 or 0, 1, and 6 months.
Results. All regimens induced (greater than or equal to 10 mIU/mL of anti-H
Bs in greater than or equal to 95% of vaccinees. Geometric mean titers rang
ed from 674.8 to 3049.4 mIU/mL. Geometric mean titers were higher with regi
mens using the following: 1) 10 versus 5 mug; 2) 3 versus 2 doses; and 3) v
accination intervals of 6 versus 4 months. After 6 months, 63.8% of vaccine
es given one 10-mug dose had greater than or equal to 10 mIU/mL of anti-HBs
Ab versus 41.6% after one 5-mug dose. Participants vaccinated with either t
wo or three 5-mug doses retained robust immunologic memory.
Conclusions. The results of this study show that a 2- dose regimen of Recom
bivax HB is as immunogenic and induces immunologic memory as effectively as
the recommended 3-dose regimen. A regimen of two 10-mug doses may be of si
gnificant benefit for vaccinees who are poorly compliant or deviate from th
e intended vaccination schedule.